A Case Report for Stage ⅢB Squamous Cell Lung Carcinoma Patient Treated with Cultured Wild Ginseng Pharmacopuncture Therapy

Objective : To derive further studies evaluating the effectiveness of Cultured Wild Ginseng Pharmacopuncture (CWGP) Therapy on squamous cell carcinoma as a first line. Methods : Three cycles (4 weeks/cycle) of CWGP were administered as a dosage of 10 ml per day. Patient was diagnosed with stage IIIB...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmacopuncture Vol. 10; no. 3; pp. 143 - 147
Main Authors Bong-Ky Park, Chong-Kwan Cho, Ki-Rok Kwon, Hwa-Seung Yo
Format Journal Article
LanguageEnglish
Published Korean Pharmacopuncture Institute 31.12.2007
Subjects
Cultured Wild Ginseng Pharmacopuncture
Disease Free Survival
Squamous cell lung cancer
Stable Disease
Online AccessGet full text

Cover

More Information
Summary:Objective : To derive further studies evaluating the effectiveness of Cultured Wild Ginseng Pharmacopuncture (CWGP) Therapy on squamous cell carcinoma as a first line. Methods : Three cycles (4 weeks/cycle) of CWGP were administered as a dosage of 10 ml per day. Patient was diagnosed with stage IIIB squamous cell carcinoma and refused all therapy of conventional medicine because of old age and cardiac invasion of tumor. Intensive treatment of CWGP for 3 cycles was done on the patient. Computed Topography (CT) was performed to evaluate the therapeutic efficacy. Results : After the intravenous infusion of 2 cycles of CWGP, chest CT revealed the mass size and pleural invasion sustained stable disease. After the point injection of 1 cycle of CWGP, chest CT revealed progressive disease. The disease free survival rate was 1 month. Conclusion : This case may provide us the possibility that CWGP offers potential benefits for patients with squamous cell lung carcinoma. But this is a single case study and further case-series research should be compensated.
ISSN:2093-6966
2234-6856
DOI:10.3831/KPI.2007.10.3.143